Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma | Zendy

HwaiI Yang | Zendy; ShengNan Lu | Zendy; YunFan Liaw | Zendy; San–Lin You | Zendy; ChienAn Sun | Zendy; LiYu Wang | Zendy; Chuhsing Kate Hsiao | Zendy; PeiJer Chen | Zendy; DingShinn Chen | Zendy; ChienJen Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

Author(s) -

HwaiI Yang,

ShengNan Lu,

YunFan Liaw,

San–Lin You,

ChienAn Sun,

LiYu Wang,

Chuhsing Kate Hsiao,

PeiJer Chen,

DingShinn Chen,

ChienJen Chen

Publication year - 2002

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa013215

Subject(s) - hbeag , hepatocellular carcinoma , hbsag , medicine , hepatitis b virus , virology , antigen , hepatitis b , immunology , virus

The presence of hepatitis B e antigen (HBeAg) in serum indicates active viral replication in hepatocytes. HBeAg is thus a surrogate marker for the presence of hepatitis B virus DNA. We conducted a prospective study to determine the relation between positivity for hepatitis B surface antigen (HBsAg) and HBeAg and the development of hepatocellular carcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research